Stock listing
NASDAQ:RARX Ra Pharmaceuticals Inc Stock
Follow Ra Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:RARX
$47.99 USD
Close on Apr 1, 2020 · No longer trades
- Lowest – highest close
- $5.16 – $48.01 USDSince Oct 26, 2016 · lowest Apr 2, 2018 · highest Mar 31, 2020
Delisted NASDAQ:RARX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:RARX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Ra Pharmaceuticals Inc on 6ix
- Decks
- 4 decks · latest Jun 7, 2018
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (June 2018) | Investor deck | 23 slides | Jun 7, 2018 |
| Corporate Update (December 2017) | Corporate update | 29 slides | Dec 8, 2017 |
| Investor Presentation (April 2017) | Investor deck | 34 slides | Apr 4, 2017 |
| Technical Presentation (December 2016) | Technical | 6 slides | Dec 2, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past) | Director · Oct 25, 2016 – Apr 2, 2020 · Past |
| Edward Mathers Other companies: NeueHealth Inc (Director · Since at least Oct 2, 2025); MBX Biosciences, Inc. (Director · Since at least Sep 12, 2024); Senti Biosciences Holdings, Inc. (Director · Since at least Jun 8, 2022); OnKure Therapeutics, Inc. (Director · Since at least Apr 8, 2021); Trevi Therapeutics, Inc. (Director · Since at least May 7, 2019); Rhythm Pharmaceuticals, Inc. (Director · Since at least Oct 4, 2017); Inozyme Pharma Inc (Director · Jul 23, 2020 – Jun 18, 2024 · Past); Akouos Inc (Director · Jun 25, 2020 – Dec 1, 2022 · Past); Mirum Pharmaceuticals, Inc. (Director · Jul 17, 2019 – Jun 2, 2022 · Past); Synlogic Inc (Director · Dec 29, 2017 – Jun 22, 2023 · Past) | Director · Jun 28, 2018 – Apr 2, 2020 · Past |
| Alexander Cumbo Other companies: Stoke Therapeutics, Inc. (Director · Since at least Sep 23, 2026); Vor Biopharma Inc. (Chair of the Compensation Committee · Since at least Jul 16, 2025); Climb Bio, Inc. (Director · Since at least Mar 28, 2025); Solid Biosciences Inc. (President and CEO, Director · Since at least Dec 2, 2022); Verve Therapeutics Inc (Director · Since at least Jun 9, 2022); Sarepta Therapeutics, Inc. (EVP, Chief Commercial Officer · Mar 5, 2018 – Feb 28, 2020 · Past) | Director · Nov 14, 2018 – Apr 2, 2020 · Past |
| Timothy R. Pearson Other companies: Korro Bio, Inc. (Director · Since at least Nov 3, 2023); Tesaro Inc (Exec. VP, CFO · May 27, 2014 – Jan 22, 2019 · Past); Crescent Biopharma, Inc. (Director · Mar 31, 2014 – May 1, 2024 · Past); Catalyst Health Solutions Inc (EVP & Chief Financial Officer · Aug 22, 2011 – Jul 2, 2012 · Past) | Director · Oct 25, 2016 – Apr 2, 2020 · Past |
| Jason Lettmann Other companies: ALX Oncology Holdings Inc. (Chief Executive Officer · Since at least Jul 16, 2020) | Director · Oct 25, 2016 – Jun 20, 2017 · Past |
| Alonso Ricardo | See Remarks · Feb 24, 2019 – Apr 2, 2020 · Past |
| John C King | Chief Commercial Officer · Apr 16, 2018 – Apr 2, 2020 · Past |
Log in to ask 6ix AI your own questions about Ra Pharmaceuticals Inc.